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The vascular endothelium plays an essential role in the control of the blood flow. Pharmacological agents like quinone (menadione)
at various doses modulate this process in a variety of ways. In this study, Q7, a 2-phenylamino-1,4-naphthoquinone derivative,
significantly increased oxidative stress and induced vascular dysfunction at concentrations that were not cytotoxic to endothelial
or vascular smooth muscle cells. Q7 reduced nitric oxide (NO) levels and endothelial vasodilation to acetylcholine in rat aorta.
It also blunted the calcium release from intracellular stores by increasing the phenylephrine-induced vasoconstriction when
CaCl
2
was added to a calcium-free medium but did not affect the influx of calcium from extracellular space. Q7 increased the
vasoconstriction to BaCl
2
(10−3M), an inward rectifying K+ channels blocker, and blocked the vasodilation to KCl (10−2M) in
aortic rings precontracted with BaCl
2
. This was recovered with sodium nitroprusside (10−8M), a NO donor. In conclusion, Q7
induced vasoconstriction was through a modulation of cellular mechanisms involving calcium fluxes through K+ channels, and
oxidative stress induced endothelium damage. These findings contribute to the characterization of new quinone derivatives with
low cytotoxicity able to pharmacologically modulate vasodilation.
1. Introduction
A functional vascular endothelium could have major clinical
implications in pathologies such as cardiovascular disease,
diabetes, and cancer [1, 2]. Previous studies have shown that
the treatment with quinone-related compounds (i.e., 1,4-
naphthoquinone derivatives) can impair [3, 4] or improve
vascular functions [5].Theunderlyingmechanism(s) of quin-
one on vascular functions are still not fully understood. For
instance, the observed decreased relaxation and increased
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contraction of blood vessels induced by menadione was
partly explained by inhibition of NO pathway via the for-
mation of reactive oxygen species (ROS). The hypotension
and vasorelaxation effects of naphthoquinone-oxime were
suggested to be due to activation of soluble guanylate cyclase
(sGC), K+ channels, and via NO pathway [6].
Quinones are widely distributed molecules in nature,
and they are found as endogenous compounds of biolog-
ical importance (i.e., coenzyme Q in mitochondrial elec-
tron chain; vitamin K
2
in blood coagulation) in humans.
Numerous therapeutic drugs, in particular antitumor com-
pounds, are quinone-bearing molecules including anthra-
cyclines (doxorubicin, mitoxanthrone, and daunarubicin),
benzoquinones (mitomycin C, geldanamycin), orthonaph-
thoquinones like 𝛽-lapachone, and several synthetic com-
pounds which are currently under clinical trials using 1,4-
naphthoquinone as pharmacophore group [6–9]. They are
reported to cause cytotoxic effects through varied mech-
anisms such as DNA intercalation, reductive alkylation of
biomolecules, and ROS formation through a redox-cycling
reaction [10–12]. Regarding this latter mechanism, quinone
reduction by 1 or 2 electrons from NADPH-cytochrome
P450 reductase leads to a semiquinone free radical which
is oxidized back to the former quinone in the presence of
molecular oxygen, while oxygen is reduced to superoxide
anion [13]. This redox-cycling leads to the formation of other
ROS, such as hydrogen peroxide and hydroxyl radicals [14,
15]. Based on this redox-cycling property, several quinones
have been used as therapeutic agents against several diseases
and pathologies [16–18]. As such they induced cell death by
either apoptosis or necrosis, inhibiting cancer cells growth
[19–21]. They also activated a senescence program leading to
cell cycle arrest [22, 23].
Our observations were that one arylamino-naphthoquin-
one derivative, namely, Q7 [2-(4-hydroxyphenyl)amino-1,4-
naphthoquinone], was able to provoke a drop in ATP
cell content and inhibit cancer cell proliferation [24]. This
inhibition induced cancer cells senescence [10], reduction
of DNA damage, and inhibition of in vivo tumor growth
[11]. It also leads to an inhibition of in vivo tumor progres-
sion by triggering apoptosis, cell cycle arrest, suppression
of HIF-1, and uncoupling glycolytic metabolism [25]. All
these effects have been attributed to its ability to generate
ROS through quinone redox-cycling. Meanwhile, it has been
reported that some naphthoquinone derivatives are potent
inhibitors of endothelium-dependent vasodilation via an
inhibition of endothelial NOS, possibly by interacting with
the reductase domain of the enzyme [4, 26]. Indeed, it
has been reported that oxidative stress enhances vascu-
lar reactivity, most likely by increasing the formation of
ROS and decreasing the availability of nitric oxide [27,
28].
Based on these facts and due to the critical role of vascular
functions in different pathologies, we have explored new
biological activities of Q7 as to be used beyond the context
of cancer, especially as it interferes with oxidative stress and
vascular function (reactivity and endothelium), an integral
complex involved in the survival or death of these cancerous
cells.
2. Materials and Methods
2.1. Cell Culture. Human umbilical vein endothelial cells
(HUVEC) were isolated by collagenase 0.25mg/mL, Colla-
genase Type II from Clostridium histolyticum (Boehringer,
Mannheim, Germany) digestion from umbilical cords ob-
tained at birth frompregnancies and cultured (37∘C, 5%CO
2
)
in 1% gelatin-coated petri dishes up to passage 2 in medium
199 (M199; Life Technologies, Carlsbad, CA,USA) containing
5mmol/L D-glucose, 10% new born bovine serum, 10% fetal
bovine serum (FBS), 3.2mmol/L L-glutamine, and 100U/mL
penicillin-streptomycin (primary culture medium). A7r5
cells, a vascular smooth muscle cell (VSMC) line originally
derived from embryonic rat aorta, were purchased from
the American Type Culture Collection (ATCC). They were
cultured in Dulbecco’s Modified Eagle Medium (DMEM; In-
vitrogen, NY, USA, Sigma-Aldrich) supplemented with 10%
FBS and 2 × 10−3M pyruvate. Prior to experiments, 80–90%
confluent A7r5 cells were serum-starved.
2.2.MTS Reduction Assay. Briefly, cells (50–60% confluence)
were seeded in 96-well plates. Cells were incubated at 37∘C in
a humidified 5% CO
2
/95% air mixture. HUVECs and A7r5
vascular smooth cell line were incubated in the absence or
in the presence of Q7 (10−7M, 10−6M, 10−5M, and 10−4M)
for 48 h, and cytotoxicity was determined using the MTS
[3-(4,5-dimethylthiazol-2-yl)-5-(3carboxymethoxyphenyl)-
2-(4-sulfophenyl)-2H-tetrazolium] reduction assay. Cell
Titer 96 AQueous One Solution Cell Proliferation Assay,
Promega,WI, USA. Cyclophosphamide (10−4M) was used as
negative control and 10−5M epirubicin (anthracycline drug
used for chemotherapy) as positive control. The MTS and
Q7 were dissolved in vehicle (DMSO) at final concentration
less than 0.1%. All the assays were performed in quintupled
and in 3 independent experiments. The cytotoxicity was
calculated in accordance with the formula: cytotoxicity
(%) = (1 − (absorbance sample/absorbance control)) × 100.
The absorbance of sample was determined in the absence
(vehicle; control) or in the presence of Q7. The absorbance
was measured with a microplate reader (Infinite 200 PRO;
Tecan, Switzerland) at 490 nm.
2.3. Animals. Male and female Sprague–Dawley rats (4-5
weeks of age, 120–180 g) from the breeding colony at the
Antofagasta University were used for this study. All rats were
housed in a temperature-controlled, light-cycled (08:00–
20:00 hours) room with ad libitum access to drinking water
and standard rat chow (Champion, Santiago). The assays
were conducted according to the Guide for the Care and
Use of Laboratory Animals published by the U.S. National
Institutes of Health (NIH Publication revised 2013), and the
local animal research committee approved the experimental
procedure used in the present study.
2.4. Isolation of Aortic Rings. Rats were sacrificed through
cervical dislocation. The thoracic aorta was quickly excised
and placed in cold (4∘C) physiological Krebs-Ringer bi-
carbonate buffer (KRB) containing (×10−3M) 4.2 KCl, 1.19














and 5 D-glucose (pH 7.4). Rings (3–5mm and 2–4mg)
were prepared after connective tissue was cleaned out from
the aorta, taking special care to avoid endothelial damage.
Aortic rings were equilibrated for 40min at 37∘C by constant





2.5. Vascular Reactivity Experiments. Aortic rings of native
animals were incubated (30min) and perfused acutely with
Q7 (10−6M and 10−5M) in the organ bath. The aortic rings
from the same animal were studied in duplicate, using differ-
ent vasoactive substances (phenylephrine [PE], acetylcholine
[ACh], sodium nitroprusside [SNP], KCl). The rings were
mounted on two 25-gauge stainless steel wires; the lower one
was attached to a stationary glass rod and the upper one
was attached to an isometric transducer (Radnoti, Monrovia,
California). The transducer was connected to a PowerLab
8/35 (Colorado Springs CO) for continuous recording of
vascular tension using the LabChart 8 computer program
(ADS Instruments).
After the equilibration period, the aortic rings were
stabilized by 2 successive near-maximum contractions with
KCl (6 × 10−2M) for 10min. The passive tension on aorta
was 1.0 g, which was determined to be the resting tension for
obtaining maximum active tension induced by 6 × 10−2M
KCl. Ten min after contraction with phenylephrine (PE;
10−6M), cumulative concentrations of acetylcholine (ACh)
were added to themedium (10−8 to 10−5M). Similar protocols
were repeated with SNP (10−8 to 10−6M). To study the role
of extracellular calcium, experiments were performed with












5 D-glucose (pH 7.4). The aortic rings were preincubated
in a KRB with calcium for 30min; then the KRB was
changed with KRB without calcium for 5min before PE
(10−6M) was added. Five min after contraction with PE
(10−6M), cumulative concentrations of CaCl
2
(0.1 to 1.0 ×
10−3M) were added to the medium. In other experiments
the contraction was induced by 10−3M BaCl
2
for 10min
and then relaxed with 10−2M KCl. BaCl
2
is used because it
increases vasoconstriction by blocking of inward rectifying
K+ channels [29–31], thus depolarizing the plasma mem-
brane.
2.6. Lipid Peroxidation. Thiobarbituric acid reactive sub-
stances (TBARS) were measured in rat aorta homogenates.
Samples of homogenates (500𝜇L; 10 ± 1.4mg protein/mL)
were incubated with vehicle andQ7 (10−6–10−4M) for 30min
and then centrifuged at 3000×g for 20min at 4∘C. A 100 𝜇L
aliquot of the supernatant was mixed with 200𝜇L of 10%
trichloroacetic acid (TCA) and 4%butylated hydroxytoluene.
The mixture was then centrifuged and 140 𝜇L of supernatant
(in duplicate) wasmixedwith thiobarbituric acid (0.67%) and
heated for 1 h at 95∘C. After cooling to room temperature,
280𝜇L of butanol-pyridine (15 : 1) was added. After centrif-
ugation (3000×g, 20min) the absorbance was measured at
532 nm.
2.7. Nitrite/Nitrate Assay. The production of NO by a seg-
ment of the rat aorta (in native rats) was measured by
nitrite accumulation using the Griess reaction method [32].





for 40min at 37∘C. KRB containing













, and 5 D-glucose (pH 7.4). Aortic
rings were incubated at 37∘C for 30min with saline, ACh
(10−5M)or the combination ofACh (10−5M)andQ7 (10−5M)
or ACh (10−5M) plus Nw-nitro-L-arginine methyl ester (L-
NAME; 10−4M). At the end of incubation, samples were
collected and nitrate reduction was carried out with Zn
dust for 30min at room temperature. Total nitrites in each
sample were determined by the addition of 1% sulfanilamide,
followed by 0.1% N-(1-naphthyl) ethylenediamine (NED) in
5% phosphoric acid. The absorbance was measured with a
microplate reader (Infinite 200 PRO; Tecan, Switzerland) at
550 nm.Nitrite concentrationwas expressed as 𝜇M/mg tissue
and calculated from a standard curve with sodium nitrite.
2.8. L-Citrulline Assay. NOS activity was determined by
incubation of HUVECs with 10−4M L-arginine and 9 × 10−6
Ci/mL L-[3H]arginine (30 minutes, 37∘C) in the absence or
presence of 10−4M L-NAME (a NOS inhibitor). In addition,
10−5M Q7 was used. HUVECs were incubated in HEPES
buffer containing (×10−3M) 50 HEPES, 100 NaCl, 5 KCl, 2.5
CaCl
2
, and 1 MgCl
2
(pH 7.4).The fraction of L-[3H]citrulline
formation inhibited by L-NAME was considered NOS activ-
ity [33]. Digested cells (95% formic acid) were passed through
an ion-exchange resin Dowex-50W 5 (50X8-200) and L-
[3H]citrulline was determined in H
2
O eluate as described
[34]. NOS activity was calculated by subtracting L-NAME-
insensitive L-citrulline from the total L-citrulline.
2.9. Determination of Intracellular Calcium in Culture Cell.
A7r5 cells were cultured in 35mm culture dish for confocal
microscopy (ibidi, Germany). The cells were washed with





, 10 HEPES, and 5.6 glucose, pH 7.4. Then,
they were loaded with 10−5M Fluo-3-AM for 25min at 37∘C
and then were again washed with Krebs without calcium
containing (×10−3M) 145 NaCl, 5 KCl, 1 MgCl
2
, 10 HEPES-
Na, and 5.6 glucose, pH 7.4. In Krebs free-calcium 5 × 10−5M
BAPTA-AM was used. The cells were preincubated in Krebs
without calcium for 5min before PE (10−6M) was added, and
then 10−3Mof CaCl
2
was added to themedium.The intensity
of Ca2+ fluorescence was measured with a laser scanning
confocal microscope (Leica TCS SP8, Concord, ON, Canada)
and fluorescence was recorded every 5 seconds. Analysis
involved determination of pixels assigned to each cell using
Image J software. The average pixel value allocated to each
cell was obtained with excitation at 506 nm and corrected for
background.
2.10. Chemicals. The following drugs were used in this study:
L-phenylephrine hydrochloride (PE; Sigma-Aldrich, St.
Louis, Mo), acetylcholine chloride (ACh; Sigma-Aldrich,






































































































Figure 2:Q7 does not induce cell death.The results show thatQ7 cytotoxicity was low or negligible on a vascular endothelial cell or vascular
smooth muscle cell line, respectively.Q7 cytoxicity was determined by MTS assay. Human umbilical vein endothelial cells (HUVEC) (a) and
A7r5 vascular smooth cell line (b) were incubated in the absence or in the presence of Q7 (10−7 to 10−4M) for 48 h. Cyclophosphamide (Cyclo;
10−4M) was used as negative control and epirubicin (Epirub; 10−5M) as positive control. The cells were seeded at 50% density. Data are the
average ± SEM of 4 independent experiments; ∗𝑝 < 0.05; ∗∗𝑝; ∗∗∗𝑝 < 0.001 versus control.
Munich, Germany), sodium nitroprusside (SNP; Merck,
Darmstadt, Germany), barium chloride dihydrate (BaCl
2
;
Sigma-Aldrich, St. Louis, MO), sulfanilamide (Sigma-Al-
drich, St. Louis, MO), N-(1-naphthyl)ethylenediamine(NED;
Sigma-Aldrich, St. Louis, MO), tetramethoxypropane (Sig-
ma-Aldrich, St. Louis, Mo), thiobarbituric acid (Merck,
Darmstadt, Germany), butylated hydroxytoluene (Merck,
Darmstadt, Germany), Nw-nitro-L-arginine methyl ester
(L-NAME; Sigma-Aldrich, St. Louis, MO), and BAPTA-
AM (Invitrogen, USA). Drugs were dissolved in distilled
deionized water. The solutions in Krebs-Ringer bicar-
bonate (KRB) were freshly prepared before each experiment.
Figure 1 shows chemical structure of 2-[(4-hydroxyphen-
yl)amino]-1,4-naphthoquinone (Q7; 265.07 g/mol); it was
synthesized by amination of 1,4-naphthoquinone with





O as the Lewis acid catalyst as previously reported
[35].
2.11. Statistical Analysis. Values are expressed as mean ±
standard error of the mean; 𝑛 denotes the number of animals
studied. One- or two-way analysis of variance (ANOVA) was
carried out to detect significant differences, followed by
Bonferroni post-tests to compare all groups. A 𝑝 value of
<0.05 was considered statistically significant.
3. Results
3.1. Cytotoxicity of Q7 on Vascular Endothelial Cell Line and
Vascular Smooth Muscle. Because oxidative stress is asso-
ciated with cell death, the effect of Q7 on the viability of
HUVEC and the vascular smooth muscle cell line A7r5 was
assessed (Figure 2). After 48 h of incubation, the cytotoxicity
in presence of 10−5M Q7 did not significantly increase in
endothelial cells (1.00 ± 0.05% in control versus 7.39 ±
6.14%with 10−5MQ7) and increased significantly in vascular
smooth muscle cells (0.97 ± 0.03% in control versus 32.20 ±
4.04% with 10−5MQ7; 𝑝 < 0.01). As expected, no significant
cytotoxicity was observed with the chemotherapy cyclophos-
phamide (10−4M), which is activated only after metabolism
in the liver and thus is inactive in cell culture.
3.2. Q7 Induces Oxidative Stress in Rat Aorta and Decreases
Endothelial NO Production in Rat Aorta. We conducted
experiments to evaluate oxidative stress revealed by Q7-
mediated lipid oxidation in rat aorta tissue. TBARS assay





































































Figure 3: Q7 produces oxidation of lipids and decreases endothelial NO. Depicting oxidative stress revealed by Q7-mediated lipid oxidation
and a change of endothelial NO release in rat aorta tissue. The rat aorta homogenate determination of TBARS in presence of Q7 (10−6 and
10−5M) was measured as % with respect to control (a). Significant differences were found between 10−5M Q7 versus control or 10−6M of
Q7 (∗𝑝 < 0.05). The production of NO by a segment of the rat aorta was measured by the accumulation of nitrite using Griess reaction
method (b): the aortic rings were incubated with vehicle (control), 10−5M ACh, 10−5M Q7 plus 10−5M ACh, and 10−5M ACh plus 10−4M
L-NAME. Data are the average ± SEM of 5 independent experiments. ∗∗∗𝑝 < 0.001 versus control; ###𝑝 < 0.001 versus ACh; effect of Q7 on
eNOS activity and production of endothelial NO (c).The production of NO was determined indirectly by the formation of L-citrulline in the
reaction catalyzed by eNOS inHUVEC.The results are mean standard error of themean. Asterisk indicates statistically significant differences
compared to the control (∗𝑝 < 0.05; 𝑛 = 3).
was used as an index of lipid peroxidation. As shown in
Figure 3(a), Q7 (10−5M) increased the formation of TBARS
by 114 ± 5% as compared to control (vehicle).
To unravel the modulatory effects on mechanisms
involved in vasodilation, NO formation in rat aorta was
assessed by measuring the production of nitrites using the
Griess reaction.The aortic rings were incubated with vehicle,
ACh (10−5M), and Q7 (10−5M) + ACh (10−5M) for 30min.
Figure 3(b) shows that the preincubation with Q7 signifi-
cantly decreased the formation of endothelial NO (8.1 ± 1.2
nitrite 𝜇M/mg tissue with ACh versus 3.7± 0.5 nitrite 𝜇M/mg
tissue with Q7 + ACh, 𝑝 < 0.01). The preincubation with L-
NAME also decreased significantly the production of nitrites
(2.9 ± 0.4 nitrite 𝜇M/mg tissue with L-NAME + ACh, 𝑝 <
0.01).
We measured eNOS activity in presence of Q7 by the
formation of L-citrulline in the reaction catalyzed by eNOS
in HUVEC (Figure 3(c)). The concentration of L-citrulline
formed is directly proportional to the NO concentration
formed and eNOS activity. We showed that Q7 (10−5M)
increased the concentration of L-citrulline in HUVEC (4.29
± 2.46 pmol/𝜇g protein control, 12.99 ± 2.22 pmol/𝜇g protein
with 10−5MQ7; 𝑝 < 0.05).
To test whether decreased or increasedNOmight have an
effect on vasodilation, we tested the modulatory effect of Q7
on ACh-induced vasodilation and PE-induced vasoconstric-
tion (Figures 4 and 5).
3.3. Endothelial Vasodilation of Rat Aortic Rings Induced by
ACh Is Impaired byQ7. To confirm thatQ7 impairs endothe-
lial dependent vasodilation via a NO pathway, further exper-
iments were conducted in PE (10−6M) precontracted aortas
and doses of either ACh (10−8–10−5M; Figures 5(a)–5(c)) or
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Organ bath:


















Figure 4: Vascular reactivity experimental setup. Aortic ring was mounted on two steel wires; the upper one was attached to an isometric
transducer. An equilibration period and stabilization with KCl were allowed, and the tissue was washed two times with fresh KRB. Then, we
performed the protocol of the experiment; we added different concentrations of PE, which caused vasoconstriction of aortic ring. To finish,
data were registered in the computer. The increase of the trace of the screen indicates vasoconstriction to PE, while the decrease of the trace
indicates vasodilatation of the aortic ring.
SNP (10−10–10−6M; Figure 5(d)) were increased. As shown
in Figures 5(b) and 5(c), preincubation for 30min with Q7
(10−5M) results in a significant decrease of ACh-mediated
vasodilation of intact aortic rings: 115 ± 2% control versus
73 ± 3% with 10−5MQ7 (10−5MACh; 𝑝 < 0.05). This finding
suggests that Q7 decreases the endothelial nitric oxide,
ACh-induced, which agrees with decreased production of
nitrites observed in previous experiments. Nevertheless, by
applying the same experimental protocol and using a NO-
donor compound, namely, SNP, a vasodilation of 100% was
observed even in the presence of 10−5M Q7 (Figure 5(d)).
This indicates that the reduction of vasodilation can be
overcome by NO; therefore, Q7 only impairs the endothelial
response and there was no response of vascular smooth
muscle.
In the next experiments, we studied if the decreased
vasodilation should be accompanied by reduced intracellular
calcium in precontracted aorta with PE.
3.4. Effect ofQ7 on the CalciumHomeostasis in A7r5 Cells. To
investigate if the contractile response of PE in presence of Q7
could be modulated by calcium released from intracellular
stores, further experiments were conducted with PE in A7r5
cells in a calcium-free medium. Figure 6 shows that this
situation, 10−5MQ7,drastically blunted the release of calcium
from intracellular stores in response to 10−6M PE, but it
however, did not blunt the increase of intracellular calcium
when 1mM CaCl
2
was added to extracellular space.
In order to gain insight into potential role of Q7 on
vascular reactivity, we repeat a similar protocol in response
to PE in aortic rings.
3.5. Effect of Q7 on Aortic Rings Vasoconstriction Induced
by PE. The effect of Q7 preincubation on the contractility
response to PE was explored. As shown in Figure 7(a), Q7
at 10−5M did not potentiate the contractile effect induced by
PE when tested in the presence of normal KRB (1.3 × 10−3M
extracellular calcium). However,Q7 enhanced the contractile
response to PEwhen calciumwas added to extracellular space
in a calcium-free medium. No change in the basal tension
of aortic rings was observed by Q7 per se. We investigated if
the contraction induced by PE in presence of Q7 could be
modulated by calcium inflow from the extracellular space.
Thus, we added increasing concentrations of CaCl
2
to a
calcium-free medium. Figure 7(b) shows that in the presence
of 10−3M CaCl
2
, Q7 (10−5M) significantly increased the
contractile response to PE (10−6M) from 128 ± 1% control
to 158 ± 9% (𝑝 < 0.05). Percentages were determined with
respect to submaximal contraction with 6 × 10−2M KCl.
This data suggests that Q7 increased calcium influx thus
enhancing PE-induced vasoconstriction.
3.6. Role of PotassiumChannels in the Vascular Response toQ7
in Rat Aortic Rings. The putative role of potassium channels
on vascular contractile response was further studied. For this









































































Figure 5: Q7 impairs ACh-induced vasodilation in an NO-dependent mechanism. Original trace showing the time course of the
concentration–response curves to PE (10−9–10−6M) and ACh (10−8–10−5M) in intact aortic rings of rats: control (a) and in the presence
of 10−5M Q7 for 30min (b). After an equilibration period and before PE, the aortic rings were stabilized by two successive near-maximal
contractions with 6 × 10−2MKCl. ACh-response curves in endothelium-intact rat aorta in the presence or absence (control) of Q7 (10−6M,
10−5M) (c). Arteries were preconstricted with 10−6MPE. SNP-response curves in rat aorta in the presence or absence (control) of 10−5MQ7
(d). Data are the average ± SEM of 4-5 independent experiments. ∗𝑝 < 0.05 versus control.
purpose, BaCl
2
was used, as it increases vasoconstriction
by blocking voltage-dependent Ca2+-sensitive K+ channels.
Figure 8(a) shows that preincubation with Q7 significantly
enhanced the contractile response to BaCl
2
(10−3M): 125 ±
3% control versus 161 ± 15% with 10−5M Q7 (𝑝 < 0.05).
Interestingly, low concentrations of KCl caused repolariza-
tion and decreased the vasoconstriction, but, in the presence
of Q7, 10−2M KCl did not decrease the vasoconstriction
provoked by BaCl
2
. Only when a NO donor (10−8M SNP)
was added to the preparation, the aortic rings were able
to recover 100% of its vasodilation, reaching values similar
to control conditions (Figure 8(b)). These data suggest that
potassium channels are required for the modulatory effect of
Q7 on vascular contractile response and in consequence, the
compound might affect the membrane potential.
4. Discussion
The modulation of blood flow through the vascular endo-
thelium influences the progression of several pathologies
8 Oxidative Medicine and Cellular Longevity
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Figure 6: Quinone effect on intracellular Ca2+ levels in A7r5 cells. Q7 blunted the release of calcium from intracellular stores, but not the
influx of calcium from extracellular space. Representative plots of relative changes in Ca2+ signal (fluo-3 fluorescence) over time on A7r5 cells
in calcium-free medium with 10−6M phenylephrine (PE) in absence of Q7 (control) (a) or presence of 10−5MQ7 (b). Data are the average ±
SEM (𝑛 = 3).
10−5 M Q7
Control




































Figure 7:Q7 increases PE-dependent vasoconstriction in a Ca2+-dependent manner. PE-response curves in endothelium-intact rat aorta in
the presence or absence (control) of 10−5M Q7 (a). The vascular tissue was preincubated in a KRB buffer without calcium for 10min before
10−6M PE was added; and then, the CaCl
2
(0.1, 0.3, 0.6, and 1.0 × 10−3M) was added to the bath (b). Data are the average ± SEM of 4-5
independent experiments. ∗𝑝 < 0.05 and ∗∗𝑝 < 0.01 versus control.
[36, 37]. Although studies have shown that quinone related
compounds can impair vasodilation by endothelial dysfunc-
tion [3, 4, 38], the effect of quinones on endothelial function
at low concentrations is not well characterized.
We found that noncytotoxic doses of Q7 induces oxida-
tive stress and reduces the formation of endothelial NO
in rat aorta, thus decreasing endothelial NO-dependent
vasodilation. Our findings are consistent with a probable
mechanism in which oxidative stress and decrease of NO
may partially block potassium channels, thus depolarizing
the cell membrane leading in consequence to the opening
of calcium channels, increased calcium influx, and thus
increasing calcium-dependent vasoconstriction.
Herein, we show that Q7 cytotoxicity after 48 h on vas-
cular endothelial cell was negligible and on vascular smooth
muscle cell was low. Considering that the incubation time
in experiments conducted to determine vascular reactivity
and oxidative stress in rat aortic rings lasted 30min, it
appears unlikely that such effects are the consequence of Q7
cytotoxicity.
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Figure 8: Acute effect of Q7 on potassium channels in rat aorta. Q7 significantly decreases the vascular contractile response involved
potassium channels. The contraction with 10−3M BaCl
2
(a) and effect of 10−2M KCl (b) in rat aorta precontracted with 10−3M BaCl
2
are
shown. Open bar (control, vehicle), black bar (10−5MQ7), and striped bar (10−5MQ7 + 10−8M SNP). Percentages of contraction with BaCl
2
were determined with respect to submaximal contraction with 6 × 10−2M KCl (a), and the percentages of contraction in presence of 10−2M
KClwere determinedwith respect tomaximal contractionwith 10−3MBaCl
2
(b). Data are the average± SEMof 4-5 independent experiments.
∗𝑝 < 0.05 and ∗∗∗𝑝 < 0.001 versus control.
In the present study, we observed that Q7 significantly
increased lipid peroxidation in rat aorta homogenates, as
shown by the enhanced TBARS formation. This finding
was attributed to the capacity of Q7 to produce oxidative
stress by increasing of ROS. In previous studies, we showed
that TBARS increased in calf-thymus DNA treated with Q7
or juglone [39]. Free radicals can attack DNA at C4 of
deoxyribose generating products as propenal, which react
with 2-thiobarbituric acid and produce the TBARS formation
[40]. In both T24 and MCF-7 cells, we found that Q7
provoked elevated levels of intracellular ROS [23, 25, 35, 39].
Oxidative stress produced by Q7 is mainly due to ROS
generation through a redox-cycling mechanism as described
for other quinones [12]. This might affect critically NO levels
in the rat aorta. Q7 increased the formation of L-citrulline
in HUVEC, compatible with increased NO generation and
eNOS activity [41].This paradoxical result can be explained in
part because the ROS produced by redox-cycling of Q7 react
rapidly with generated NO, leading to a reduction of its level
[38]. Quinones (i.e., doxorubicin, menadione) increase the
generation of ROS (anion superoxide) leading to scavenging
of NO, in agreement with previously described results [42–
44]. In fact, we now found that Q7 significantly reduced the
ACh-mediated NO formation.
Accordingly, ACh-mediated endothelial vasodilation was
significantly reduced by Q7, but it was recovered when a NO
donor (SNP) was added into intact rat aorta preparations.
Therefore, endothelial dysfunction caused by Q7 may be
explained by a decrease in the bioavailability of endothelial
NO.
Oxidative stress is associated with disruption of intra-
cellular calcium homoeostasis [45]. In fact, Q7 blunted the
release of calcium from intracellular stores in response to PE
on vascular smooth muscle cell (A7r5 cells) in a free-calcium
medium. Similar results we observed in cardiac fibroblasts
preincubated withQ7 in a free-calcium medium in presence
of angiotensin II (data not shown). These findings suggest
that oxidative stress induced by Q7 blocked the release
of intracellular calcium or caused calcium leakage from
intracellular stores to extracellular space.This is in agreement
with the inhibitory effect of quinone-related compounds
(menadione) on the release of calcium from intracellular
stores [46], by inhibition of sarcoplasmic calcium ATPase
[47]. It is possible that the endoplasmic reticulum emptying
of calcium by Q7 enhanced the contractile response to PE of
aortic rings when calcium was provided extracellularly. We
found that Q7 did not decrease the influx of calcium from
extracellular space.
We have obtained preliminary data suggesting that Q7
may also inhibit potassium channels in neurons. Our results
show an increase in action potential firing that is accompa-
nied by increased input resistance (data no shown), an effect
that could be mediated by blockade of hyperpolarization-
activated cyclic nucleotide gated (HCN) channels, that carry
the Ih current [48]. However, more experiments are needed
to confirm the participation of different ion channels in this.
To study a putative role of potassium channels in
NO-dependent vasodilation, we use BaCl
2
. Barium blocks
inward rectifying potassium channels such as ATP-sensitive
K+ channels at submillimolar concentrations [49, 50] and
voltage-dependent Ca2+-sensitive K+ channels at millimolar
concentrations [29, 30]. The result of the blockage of potas-
sium channels by barium induced contraction in aortic rings.
In the presence of Q7, the addition of KCl (10−2M) was
unable to provoke a total vasodilation in rat aorta precon-
stricted with BaCl
2
(10−3M), an effect which was however
obtained at 100% by adding SNP (10−8M). The increase of
KCl over 2 × 10−2M caused repolarization and vasodilation,
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because the membrane potential moves towards the new K+
equilibrium potential, and voltage-dependent Ca2+-sensitive
K+ channels are again opened [29, 41, 51]. These findings
may be explained by previous studies, showing that juglone
(5-hydroxy-1,4-naphthoquinone) partially blocks voltage-
dependent potassium channels, causing depolarization of the
membrane [52].
These results agree with the idea that vasodilation
induced by endothelial NO is due, at least in part, to a
repolarization of the plasma membrane by opening voltage-
dependent Ca2+-sensitive K+ channels [53–55] and closing of
L-type Ca2+ channels [56], decreasing in this way the calcium
influx [57, 58].
In conclusion, oxidative stress induced by Q7 decreases
endothelial vasodilation, a process likely accompanied by
decreased NO bioavailability and partial downstream block-
ade of potassium channels and membrane depolarization,
followed by enhanced influx of calcium [59]. These findings
could have interesting and potential clinical effects for a
number of pathologies such as inflammatory disorders, dia-
betic blindness, age-relatedmuscular degeneration, psoriasis,
cardiovascular and autoimmune diseases, and cancer [60].
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